⌘K
Loading ticker…
Akari Therapeutics plc ADR (0.01 USD) · Healthcare · Pharmaceutical Products
As of 2026-06-26, Akari Therapeutics plc ADR (0.01 USD) (AKTX) has a 3-month relative strength percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 17.2%, relative volume 0.48×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 96, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AKTX Jan avg: -11.54% median: -13.34% win: 0% σ: 8.01% n: 4 2022-04-12 → 2026-05-29 | AKTX Feb avg: -13.98% median: -15.24% win: 25% σ: 11.74% n: 4 2022-04-12 → 2026-05-29 | AKTX Mar avg: -17.73% median: -33.06% win: 25% σ: 41.98% n: 4 2022-04-12 → 2026-05-29 | AKTX Apr avg: 1.52% median: 4.40% win: 60% σ: 12.20% n: 5 2022-04-12 → 2026-05-29 | AKTX May avg: 41.06% median: -1.68% win: 40% σ: 91.47% n: 5 2022-04-12 → 2026-05-29 | AKTX Jun avg: 6.44% median: -8.62% win: 25% σ: 34.39% n: 4 2022-04-12 → 2026-05-29 (current) | AKTX Jul avg: 23.05% median: 28.67% win: 75% σ: 27.59% n: 4 2022-04-12 → 2026-05-29 | AKTX Aug avg: -14.94% median: -13.62% win: 25% σ: 19.80% n: 4 2022-04-12 → 2026-05-29 | AKTX Sep avg: -2.94% median: 1.21% win: 50% σ: 38.45% n: 4 2022-04-12 → 2026-05-29 | AKTX Oct avg: -21.03% median: -22.19% win: 0% σ: 5.98% n: 4 2022-04-12 → 2026-05-29 | AKTX Nov avg: -19.90% median: -24.32% win: 25% σ: 29.66% n: 4 2022-04-12 → 2026-05-29 | AKTX Dec avg: -12.24% median: -7.07% win: 50% σ: 20.86% n: 4 2022-04-12 → 2026-05-29 |